{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/xcellerater-oversight-infosheet#webpage",
"url": "https://www.fortrea.com/insights/xcellerater-oversight-infosheet",
"name": "Xcellerate® Oversight Infosheet",
"description": "Explore this Fortrea info sheet on clinical trial oversight and discover how Xcellerate Oversight, powered by Fortrea Intelligent Technology (FIT), helps sponsors strengthen oversight across studies, programs, and clinical development portfolios. The info sheet highlights capabilities that support study oversight, quality oversight, risk oversight, and portfolio oversight, helping teams monitor trial activities, review quality and risk indicators, identify potential issues, and maintain oversight across multiple clinical studies. Learn how integrated oversight approaches can support clinical trial management, quality management processes, risk management activities, portfolio management, and clinical development oversight while helping sponsors maintain greater control and consistency throughout the clinical trial lifecycle."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "https://www.fortrea.com/insights/xcellerater-oversight-infosheet",
"item": "https://www.fortrea.com/insights/xcellerater-oversight-infosheet"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/xcellerater-oversight-infosheet#infosheet",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/xcellerater-oversight-infosheet#webpage"
},
"headline": "Clinical Trial Oversight: Study, Quality, Risk, and Portfolio Oversight | Fortrea Info Sheet",
"description": "Explore this Fortrea info sheet on clinical trial oversight and discover how Xcellerate Oversight, powered by Fortrea Intelligent Technology (FIT), helps sponsors strengthen oversight across studies, programs, and clinical development portfolios. The info sheet highlights capabilities that support study oversight, quality oversight, risk oversight, and portfolio oversight, helping teams monitor trial activities, review quality and risk indicators, identify potential issues, and maintain oversight across multiple clinical studies. Learn how integrated oversight approaches can support clinical trial management, quality management processes, risk management activities, portfolio management, and clinical development oversight while helping sponsors maintain greater control and consistency throughout the clinical trial lifecycle.",
"genre": "Info Sheet",
"image": {
"@type": "ImageObject",
"url": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png"
},
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2026-04-06",
"dateModified": "2026-04-06",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2026-04/xcellerate-oversight.pdf",
"encodingFormat": "application/pdf"
}
}
]
}